This is unpublished
	EDEN-EPO Dosing for Anemia in End-Stage Kidney Disease
Completed Studies
              CKD
          Pinned
									Principal Investigator
          Jonathan Himmelfarb
              Funding Agency
          NIH
              Status
          Completed
              Investigator
What is the EDEN-EPO Study?
The goal of this study was to improve existing EPO dosing algorithms, with the hope that this will lead to a more personalized and accurate dosing of EPO in people with end-stage renal disease.